Defining the characteristics of leukemia stem cells is critical in order to better understand both the genesis of leukemic disease and strategies by which such cells may be eradicated. In this issue of Cancer Cell, Somervaille and Cleary describe studies in which the properties of malignant stem cells are elucidated in a mouse model of leukemia induced by expression of the MLL-AF9 translocation. Biological features of leukemia stem cells in this system challenge previous thinking in several ways and suggest an unexpected degree of heterogeneity among stem cells in various forms of leukemia
Recent studies (Shlush et al., 2014; Corces-Zimmerman et al., 2014) have demonstrated that leukemias...
Acute Myeloid Leukemia (AML) is a severe disease with a very high relapse rate. AML relapse may be a...
AbstractMost hematopoietic malignancies are comprised of cells that are functionally heterogeneous, ...
Defining the characteristics of leukemia stem cells is critical in order to better understand both t...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
SummaryUsing a mouse model of human acute myeloid leukemia (AML) induced by the MLL-AF9 oncogene, we...
Genetically engineered mouse models are powerful systems for dissecting the process of human leukemo...
In this issue of Cancer Cell, Goardon et al. revise earlier conclusions regarding acute myelogenous ...
We have recently shown that in childhood acute lymphoblastic leukemia (ALL) blasts at different stag...
SummaryFaithful modeling of mixed-lineage leukemia in murine cells has been difficult to achieve. We...
MLL rearrangements in humans lead to both acute myeloid leukemia (AML) and acute lymphoid leukemia (...
There is now compelling evidence to show that tumors, once believed to be a homogeneous mass of abno...
Identification and characterization of leukemia-initiating cells (LICs) is important to understand l...
Recent studies (Shlush et al., 2014; Corces-Zimmerman et al., 2014) have demonstrated that leukemias...
Acute Myeloid Leukemia (AML) is a severe disease with a very high relapse rate. AML relapse may be a...
AbstractMost hematopoietic malignancies are comprised of cells that are functionally heterogeneous, ...
Defining the characteristics of leukemia stem cells is critical in order to better understand both t...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
The blood-related cancer leukemia was the first disease where human cancer stem cells (CSCs), or leu...
SummaryUsing a mouse model of human acute myeloid leukemia (AML) induced by the MLL-AF9 oncogene, we...
Genetically engineered mouse models are powerful systems for dissecting the process of human leukemo...
In this issue of Cancer Cell, Goardon et al. revise earlier conclusions regarding acute myelogenous ...
We have recently shown that in childhood acute lymphoblastic leukemia (ALL) blasts at different stag...
SummaryFaithful modeling of mixed-lineage leukemia in murine cells has been difficult to achieve. We...
MLL rearrangements in humans lead to both acute myeloid leukemia (AML) and acute lymphoid leukemia (...
There is now compelling evidence to show that tumors, once believed to be a homogeneous mass of abno...
Identification and characterization of leukemia-initiating cells (LICs) is important to understand l...
Recent studies (Shlush et al., 2014; Corces-Zimmerman et al., 2014) have demonstrated that leukemias...
Acute Myeloid Leukemia (AML) is a severe disease with a very high relapse rate. AML relapse may be a...
AbstractMost hematopoietic malignancies are comprised of cells that are functionally heterogeneous, ...